Boon Industries, Inc. is a bioscience company that manufactures commercial chemical products with various applications in commercial sterilization for agriculture, warehousing, hospitality and medical facilities. DiOx+, our flagship product, is a disinfectant sterilizer that kills harmful pathogens without dangerous toxic exposure to the user or the environment. DiOx+ is an activated chlorine dioxide (Cl02) broad spectrum disinfectant that helps protect the environment and human health from viruses, bacteria and harmful by-products left by other cleaning sanitizers, without a harsh smell or skin irritation.
Company profile
Ticker
CSTF
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Element Solutions • Cabot • Orion S.A • Versum Materials • WD-40 • Arq • GlyEco • Flexible Solutions International • Flotek Industries • ASP Isotopes ...
Former names
Boon Industries, Inc.
SEC CIK
IRS number
845079920
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
9 Feb 24
8-K
Departure of Directors or Certain Officers
10 Jan 24
8-K
Entry into a Material Definitive Agreement
2 Jan 24
8-K
Departure of Directors or Certain Officers
8 Dec 23
10-Q
2023 Q3
Quarterly report
8 Dec 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
8-K
Entry into a Material Definitive Agreement
30 May 23
8-K
Departure of Directors or Certain Officers
30 May 23
Latest ownership filings
4
Paul Quentin Goyette
14 Oct 22
3
Paul Quentin Goyette
14 Oct 22
4
William Joseph Reed
14 Oct 22
4
William Joseph Reed
29 Sep 22
3
William Joseph Reed
29 Sep 22
SC 13G
May Davis Partners Acquisition Co LLC
28 Jun 22
3
Eric Jason Watson
4 Apr 22
3
JOHANN LOEWEN
2 Mar 22
3
Justin Michael Gonzalez
28 Feb 22
3
Edouard Maurice Beaudette
25 Feb 22
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 40.91 k | 40.91 k | 40.91 k | 40.91 k | 40.91 k | 40.91 k |
Cash burn (monthly) | 80.27 k | (no burn) | 295.17 k | 348.49 k | 84.98 k | 25.36 k |
Cash used (since last report) | 477.22 k | n/a | 1.75 mm | 2.07 mm | 505.19 k | 150.76 k |
Cash remaining | -436.31 k | n/a | -1.71 mm | -2.03 mm | -464.28 k | -109.85 k |
Runway (months of cash) | -5.4 | n/a | -5.8 | -5.8 | -5.5 | -4.3 |
Institutional ownership, Q1 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Sep 22 | William Joseph Reed | Series A Preferred Stock Common Stock | Grant | Acquire A | No | No | 0 | 500,000 | 0.00 | 515,000 |
29 Sep 22 | Paul Quentin Goyette | Series A Preferred Stock Common Stock | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 10,000 |